Research and Clinical Trials

The protein PD-L1 is frequently present on the surface of cancer cells and is known for its role in helping cancer cells escape the immune[...]

The best is yet to come. It's been 14 years since I arrived in Rochester, Minnesota, to lead Mayo Clinic Cancer Center, and the time[...]

Research from Mayo Clinic investigators presented at the 2019 San Antonio Breast Cancer Symposium suggests that some women with an elevated risk of developing breast[...]

Michael B. Wallace, M.D., a gastroenterologist at Mayo Clinic in Jacksonville, Florida, discusses his research on the early detection of pancreatic cancer.

Researchers on Mayo Clinic's Florida campus can now distinguish between two pathways where lung adenocarcinoma can develop, a discovery that could help future patients. The[...]

Despite improvements in median and short-term survival rates in glioblastoma, the percentage of patients achieving five-year survival remains low, according to new Mayo Clinic research.[...]

Using advanced technology, scientists at Mayo Clinic, Chan Zuckerberg (CZ) Biohub and the University of California San Francisco (UCSF), have discovered an autoimmune disease that[...]

According to new research from Mayo Clinic, colorectal cancer outcomes may improve by genetically altering an immune-regulatory protein in cancer cells, making the cells more[...]

Mayo Clinic has opened a new 190,000-square-foot medical building on its Florida campus for patients seeking cancer, neurology and neurosurgical care. Named in honor of[...]

Daniel D. Billadeau, Ph.D., an oncology researcher at Mayo Clinic in Rochester, Minnesota, talks about his work investigating pancreatic cancer. Dr. Billadeau is also a principal investigator of the Mayo Clinic Pancreatic Cancer SPORE.